A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Lactobionic acid | 100g Pack Size. Group: Biochemicals, Building Blocks, Carbohydrates, Research Organics & Inorganics. Formula: C12H22O12. CAS No. 96-82-2. Prepack ID 34227073-100g. Molecular Weight 358.3. See USA prepack pricing. |  |
| Lactobionic acid | 25g Pack Size. Group: Biochemicals, Building Blocks, Carbohydrates, Research Organics & Inorganics. Formula: C12H22O12. CAS No. 96-82-2. Prepack ID 34227073-25g. Molecular Weight 358.3. See USA prepack pricing. | |
| Lactobionic acid | Lactobionic acid is a bionic acid naturally found in the Caspian Sea yogurt and chemically constituted of a gluconic acid bonded to a galactose. Lactobionic acid has antioxidant, antimicrobial, chelating, stabilizer, acidulant, and moisturizing properties [1]. Uses: Scientific research. Group: Natural products. CAS No. 96-82-2. Pack Sizes: 10 mM * 1 mL; 100 mg; 250 mg; 500 mg. Product ID: HY-N7059. |  |
| Lactobionic Acid, 98-102% EP | Lactobionic Acid is used in solutions to preserve organs involved in surgical transplants. Also a potential inhibitor of Trypanosoma cruzi as a lactose derivative. Group: Biochemicals. Alternative Names: 4-( β-D-Galactosido)-D-gluconic Acid; 4-O- β-Galactopyranosyl-D-gluconic AcidD-Lactobionic Acid; Galactosylgluconic Acid. Grades: Highly Purified. CAS No. 96-82-2. Pack Sizes: 25g, 100g, 250g, 1Kg. Molecular Formula: C12H22O12, Molecular Weight: 358.3. US Biological Life Sciences. |  Worldwide |
| Lactobionic Acid BP/EP/USP | Lactobionic Acid BP/EP/USP. CAS No. 96-82-2. Molecular formula: C12H22O12. |  |
| Lactobionic acid ethyl ester |  | |
| lactocepin | Associated with the cell envelope of Lactococcus lactis and attached via a C-terminal membrane anchor sequence. Responsible for the hydrolysis of casein in milk and the provision of peptides essential to cell growth. Important in cheese making and the production of lactic casein, being required for rapid growth to high cell densities with concomitant production of adequate levels of lactic acid. Specificity differences between lactocepins from different starter strains may be partly responsible for imparting different flavour qualities to cheese. In peptidase family S8 (subtilisin family). Group: Enzymes. Synonyms: CEP; extracellular lactococcal proteinase; lactococcal cell wall-associated proteinase; lactococcal cell envelope-associated proteinase; lactococcal proteinase; PrtP. Enzyme Commission Number: EC 3.4.21.96. CAS No. 205510-58-3. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-4188; lactocepin; EC 3.4.21.96; 205510-58-3; CEP; extracellular lactococcal proteinase; lactococcal cell wall-associated proteinase; lactococcal cell envelope-associated proteinase; lactococcal proteinase; PrtP. Cat No: EXWM-4188. |  |
| Lactocin 705 | Lactocin 705 is an antibacterial peptide isolated from Lactobacillus casei CRL 705. Synonyms: Lac705α; Gly-Met-Ser-Gly-Tyr-Ile-Gln-Gly-Ile-Pro-Asp-Phe-Leu-Lys-Gly-Tyr-Leu-His-Gly-Ile-Ser-Ala-Ala-Asn-Lys-His-Lys-Lys-Gly-Arg-Leu-Gly-Tyr. Grades: 97.2%. | |
| Lactococcin G-a | Lactococcin G-a is an antibacterial peptide isolated from Lactococcus lactis LMGT2081. Synonyms: Gly-Thr-Trp-Asp-Asp-Ile-Gly-Gln-Gly-Ile-Gly-Arg-Val-Ala-Tyr-Trp-Val-Gly-Lys-Ala-Leu-Gly-Asn-Leu-Ser-Asp-Val-Asn-Gln-Ala-Ser-Arg-Ile-Asn-Arg-Lys-Lys-Lys-His. Grades: 98.1%. Molecular formula: C189H303N61O55. Mole weight: 4309.86. | |
| Lactococcin Q alpha | Lactococcin Q alpha is an antibacterial peptide isolated from Lactococcus lactis QU 4. It has activity against gram-positive bacteria. Synonyms: Ser-Ile-Trp-Gly-Asp-Ile-Gly-Gln-Gly-Val-Gly-Lys-Ala-Ala-Tyr-Trp-Val-Gly-Lys-Ala-Met-Gly-Asn-Met-Ser-Asp-Val-Asn-Gln-Ala-Ser-Arg-Ile-Asn-Arg-Lys-Lys-Lys-His. Grades: 96.9%. Molecular formula: C185H297N59O53S2. Mole weight: 4259.88. | |
| Lactococcin Q beta | Lactococcin Q beta is an antibacterial peptide isolated from Lactococcus lactis QU 5. It has activity against gram-positive bacteria. Synonyms: Lys-Lys-Trp-Gly-Trp-Leu-Ala-Trp-Val-Glu-Pro-Ala-Gly-Glu-Phe-Leu-Lys-Gly-Phe-Gly-Lys-Gly-Ala-Ile-Lys-Glu-Gly-Asn-Lys-Asp-Lys-Trp-Lys-Asn-Ile. Grades: 96.3%. Molecular formula: C192H287N49O46. Mole weight: 4017.69. | |
| Lactococcus Lactis Freeze Dried Powder | Lactococcus lactis is a Gram-positive bacterium used extensively in the production of buttermilk and cheese, but has also become famous as the first genetically modified organism to be used alive for the treatment of human disease. Applications: dietary supplements - capsules, powder, tablets. food - bars, powdered beverages. Group: Probiotics. Synonyms: Lactococcus Lactis Freeze-drying powder in Yoghurt Health Benefits; Lactococcus Lactis. Activity: 10 billion CFU/g or more. Stability: 24 Months. Appearance: White To Light Yellow-Colored, Free-Flowing Powder. Storage: Recommend storage at refrigeration (4 °C) or frozen temperature (-18 °C) in original, sealed package until processed. Form: Powder. Lactococcus Strains. Cat No: PRBT-026. | |
| Lactococcus Lactis Freeze-drying Powder | L. lactis LLa61 was isolated from yogurt. L.lactis LLa61 is of crucial importance for manufacturing dairy products, such asbuttermilk and cheeses. When L. lactis ssp. lactis is added to milk, thebacterium uses enzymes to produce energy molecules (ATP), from lactose. Thebyproduct of ATP energy production is lactic acid. L.lactis LL162 strain is a yogurt fermentation strain growing in lower temperature of 28°C, and after 8 hours fermentation, the strain can produce flavor substance and strengthen the creamy flavor of yogurt. Also, L.lactis is a nisin producer and inhibit bacteria contaminants in the yogurt. This strain is high stability as a probiotics strain in the room temperature. Group: Others. Synonyms: Lactococcus Lactis Freeze-drying powder in Yoghurt Health Benefits; Lactococcus Lactis. Purity: >90%. Stability: 24 Months. Appearance: White To Light Yellow-Colored, Free-Flowing Powder. Lactococcus Lactis Freeze-drying powder in Yoghurt Health Benefits; Lactococcus Lactis. Cat No: PRBT-026. | |
| Lactocyclicin Q | Lactocyclicin Q is an antibacterial peptide isolated from Lactococcus sp. strain QU 12. It has activity against gram-positive bacteria and gram-negative bacteria. Synonyms: Leu-Ile-Asp-His-Leu-Gly-Ala-Pro-Arg-Trp-Ala-Val-Asp-Thr-Ile-Leu-Gly-Ala-Ile-Ala-Val-Gly-Asn-Leu-Ala-Ser-Trp-Val-Leu-Ala-Leu-Val-Pro-Gly-Pro-Gly-Trp-Ala-Val-Lys-Ala-Gly-Leu-Ala-Thr-Ala-Ala-Ala-Ile-Val-Lys-His-Gln-Gly-Lys-Ala-Ala-Ala-Ala-Ala-Trp. | |
| Lactodifucotetraose | Lactodifucotetraose is a notable bioactive compound, emerging as a promising compound in studying ailments concerning the gastrointestinal realm. Its innate potential lies in fostering the proliferation of symbiotic gut microflora and catalyzing the intricate process of digestive assimilation. By virtue of its robust prebiotic attributes, Lactodifucotetraose efficaciously propels the state of gut well-being through studying inflammatory responses and fortifying the resilience of the immune system. Synonyms: LDFT; Difucosyl lactose. CAS No. 20768-11-0. Molecular formula: C24H42O19. Mole weight: 634.58. | |
| Lactofen | Lactofen is a complex ester derivative of Acifluoren, a diphenyl ether herbicide. Lactofen can be used in postemergence applications and is commonly used as foliar spray. Lactofen is used in agriculture to control broadleaved weeds in soybean, cereals, potatoes and peanuts. Group: Biochemicals. Alternative Names: Cobra; PPG 844; Phoenix; 5-[2-chloro-4- (trifluoromethyl) phenoxy]-2-nitrobenzoic Acid 2-Ethoxy-1-methyl-2-oxoethyl ester. Grades: Highly Purified. CAS No. 77501-63-4. Pack Sizes: 1g. US Biological Life Sciences. | Worldwide |
| Lactoferricin | Lactoferricin has Antimicrobial activity. Synonyms: Met-Phe-Lys-Cys-Arg-Arg-Trp-Gln-Trp-Arg-Met-Lys-Lys-Leu-Gly-Ala-Pro-Ser-Ile-Thr-Cys-Val-Arg-Arg-Ala-Phe. Molecular formula: C134H212N42O27S3. Mole weight: 2939.6. | |
| Lactoferricin-B | Lactoferricin-B is an antibacterial peptide isolated from Bos taurus. Synonyms: Lactotransferrin precursor; Phe-Lys-Cys-Arg-Arg-Trp-Gln-Trp-Arg-Met-Lys-Lys-Leu-Gly-Ala-Pro-Ser-Ile-Thr-Cys-Val-Arg-Arg-Ala-Phe. Molecular formula: C141H224N46O29S3. Mole weight: 3123.8. | |
| Lactoferricin b 15 | Lactoferricin b 15 has Antimicrobial activity. Synonyms: Pro-Met-Phe-Lys-Cys-Trp-Arg-Trp-Gln-Trp-Arg-Trp-Lys-Lys-Leu-Gly-Ala-Met. Grades: 96.8%. | |
| Lactoferricin B (4-14) (bovine) | Lactoferricin B (4-14) (bovine) is thought to be the main protecting component from bacteria at the mucosal surfaces and in colostrum and milk. The region rich in basic amino acids of bovine lactoferricin is involved in the interaction with the bacterial phospholipid membrane and plays an important role in antimicrobial activity. Synonyms: Lactotransferrin (20-30) (bovine); H-Arg-Arg-Trp-Gln-Trp-Arg-Met-Lys-Lys-Leu-Gly-OH; BLFC (4-14); L-arginyl-L-arginyl-L-tryptophyl-L-glutaminyl-L-tryptophyl-L-arginyl-L-methionyl-L-lysyl-L-lysyl-L-leucyl-glycine; Lactoferricin, bovine; Lactoferrin (20-30) (bovine); Lactoferrin (BL-11). Grades: ≥95%. CAS No. 183476-25-7. Molecular formula: C70H113N25O13S. Mole weight: 1544.87. | |
| Lactoferrin | Lactoferrin (LF), also known as lactotransferrin (LTF), to transferrin in a multifunctional glycoprotein. Lactoferrin is a globular glycoprotein with a molecular weight of 80 kDa, in a wide variety secretion of fluid, such as milk, saliva, tears, and nose. Lactoferrin is also present in the medium term in neutrophils secreted by some of the acinar cells. Lactoferrin can be extracted or using recombinant DNA technology from the milk. Applications: Food additives and infant formula. Group: Others. Lactoferrin. Cat No: EXTC-135. | |
| Lactoferrin | Lactoferrin. Uses: For analytical and research use. Group: Building blocks. Alternative Names: Lactoferrin. CAS No. 146897-68-9. Pack Sizes: 10MG. Catalog: APS146897689. Format: Neat. Shipping: Room Temperature. |  |
| LACTOFERRIN | Lactoferrin is a multifunctional globular glycoprotein of the transferrin family. Synonyms: Lactoferricin B; Lfcin B. Grades: Protein 98%. CAS No. 146897-68-9. | |
| Lactoferrin (322-329) (human) | Lactoferrin (322-329) (human) is a highly amyloidogenic region of lactoferrin. Synonyms: H-Asn-Ala-Gly-Asp-Val-Ala-Phe-Val-OH; L-asparagyl-L-alanyl-glycyl-L-alpha-aspartyl-L-valyl-L-alanyl-L-phenylalanyl-L-valine; (2S,5S,8S,11S,14S)-5-benzyl-14-(2-((S)-2-((S)-2,4-diamino-4-oxobutanamido)propanamido)acetamido)-2,11-diisopropyl-8-methyl-4,7,10,13-tetraoxo-3,6,9,12-tetraazahexadecane-1,16-dioic acid. Grades: ≥95%. CAS No. 496808-32-3. Molecular formula: C35H53N9O12. Mole weight: 791.86. | |
| Lactoferrin > 95% | Lactoferrin > 95%. |  CA, FL & NJ |
| Lactoferrin from Bovine milk | Lactoferrin from Bovine milk is a substance released by neutrophils. Lactoferrin from Bovine milk is an orally active multifunctional iron binding glycoprotein. Lactoferrin from Bovine milk prevents cell adhesion, growth and spreading of cell colonies. Lactoferrin from Bovine milk also has antiviral activity and inhibits microbial and viral adhesion and entry into host cells. Besides, Lactoferrin from Bovine milk has anti-inflammatory, immunomodulatory, and anti-cancer activities [1] [2] [3]. Uses: Scientific research. Group: Biochemical assay reagents. CAS No. 936541-36-5. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-P3161. | |
| Lactojasmone | Lactojasmone. CAS No. 7011-83-8. FEMA No. 3786. VIGON Item # 502514. Categories: Speciality Ingrdients Suppliers, Fragrances, Perfumers. |  America & Internationally |
| Lactomycin B | Lactomycin B is a polyketide isolated from the culture broth of a marine-derived Streptomyces sp. CAS No. 199394-69-9. Molecular formula: C25H39NO6. Mole weight: 449.58. | |
| Lactonamycin Z | It is produced by the strain of Streptomyces sp. AK 623. It's an antitumor antibiotic. It has weak anti-gram-positive bacterial activity. It can inhibit human tumor cells HMO2, MCF7 and Hep G2 with GI50 (μg/mL) of 1.9, 0.85 and 5.11, respectively. Molecular formula: C28H27NO13. Mole weight: 585.51. | |
| Lacto-N-biose | It is the receptor of helicobacter pylori α1,2-Focusyltransferase enzyme. Synonyms: Galβ1-3GlcNAc; Gal-b-1,3-GlcNAc; 2-Acetamido-2-deoxy-3-O-(b-D-galactopyranosyl)-D-glucopyranose; beta-D-galactsyl-(1->3)-N-acetyl-D-glucosamine; beta-D-Galactopyranosyl-(1->3)-N-acetyl-D-glucosamine; O-β-D-Galactopyranosyl-(1-3)-N-acetylglucosamine; Lewis C. Grades: ≥95%. CAS No. 50787-09-2. Molecular formula: C14H25NO11. Mole weight: 383.35. | |
| Lacto-N-biose I | Lacto-N-biose I (Galβ1-3GlcNAc), as an endogenous metabolite, is an acceptor for the α1,2-fucosyltransferase enzyme from Helicobacter pylori [1]. Uses: Scientific research. Group: Natural products. Alternative Names: Galβ1-3GlcNAc. CAS No. 50787-09-2. Pack Sizes: 1 mg; 5 mg. Product ID: HY-141488. | |
| lacto-N-biosidase | The enzyme from Streptomyces specifically hydrolyses the terminal lacto-N-biosyl residue (β-D-Gal-(1?3)-D-GlcNAc) from the non-reducing end of oligosaccharides with the structure β-D-Gal-(1?3)-β-D-GlcNAc-(1?3)-β-D-Gal-(1?R). Lacto-N-hexaose (β-D-Gal-(1?3)-β-D-GlcNAc-(1?3)-β-D-Gal-(1?3)-β-D-GlcNAc-(1?3)-β-D-Gal-(1?4)-D-Glc) is hydrolysed to form first lacto-N-tetraose plus lacto-N-biose, with the subsequent formation of lactose. Oligosaccharides in which the non-reducing terminal Gal or the penultimate GlcNAc are replaced by fucose or sialic acid are not substrates. Asialo GM1 tetraose (β-D-Gal-(1?3)-β-D-GalNAc-(1?3)-β-D-Gal-(1?4)-D-Glc) is hydrolysed very slowly, but lacto-N-neotetraose (β-D-Gal-(1?4)-β-D-GalNAc-(1?3)-β-D-Gal-(1?4)-D-Glc) is not a substrate. Group: Enzymes. Enzyme Commission Number: EC 3.2.1.140. CAS No. 146359-52-6. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-3823; lacto-N-biosidase; EC 3.2.1.140; 146359-52-6. Cat No: EXWM-3823. | |
| Lacto-N-Biosidase, Recombinant | Lacto-N-Biosidase may be used during glycoprotein analysis to better study the structure and function of glycoprotein and glycolipid sugar chains. This product can be used for specific oligosaccharide hydrolysis of type-I chain oligosaccharides, producing lacto-N-biose (Gal β 1-3 GlcNAc) as a byproduct, but not oligosaccharide hydrolysis of type-II chain oligosaccharides. As a result, Lacto-N-Biosidase can be used to distinguish type-I versus type-II glycoprotein as well as glycolipid sugar chains. When used in conjunction with α -1,3/4-Fucosidase, Lacto-N-Biosidase can also help distinguish Sialyl-Lewis x and Sialyl-Lewis a structures. Applications: Specific hydrolysis of oligosaccharides with type-i sugar chains and production of byproduct lacto-n-biose (gal β 1-3 glcnac). Group: Enzymes. Synonyms: Oligosaccharide lacto-N-biosylhydrolase; Lacto-N-Biosidase. Lacto-N-Biosidase. Mole weight: 60 kDa (SDS-PAGE). Form: Solution in 50 mM sodium acetate buffer, pH 5.5, containing 0.05% Brij-58. Source: Streptomyces sp. 142. Oligosaccharide lacto-N-biosylhydrolase; Lacto-N-Biosidase. Cat No: NATE-0855. | |
| Lacto-N-difucohexaose I | Lacto-N-difucohexaose I is an indispensable compound in the biomedical field, exhibiting remarkable immunomodulatory attributes. Its application predominantly encompasses the research of multifarious ailments, encompassing particular cancer types and autoimmune afflictions. As a propitious research, this product adeptly modulates the immune response, potentially augmenting patient outcomes with unprecedented efficacy. Synonyms: LNDFH I; Lewisb antigen; 6-Deoxy-α-L-galactopyranosyl-(1->4)-[6-deoxy-α-L-galactopyranosyl-(1->2)-β-D-galactopyranosyl-(1->3)]-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1->3)-β-D-galactopyranosyl-(1->4)-D-glucose; α-L-Fuc-(1-2)-β-D-Gal-(1-3)[α-L-Fuc-(1-4)]-β-D-GlcNAc-(1-3)-β-D-Gal-(1-4)-D-Glc. Grades: ≥95%. CAS No. 16789-38-1. Molecular formula: C38H65NO29. Mole weight: 999.91. | |
| Lacto-N-difucohexaose I-APD-HSA | | |
| Lacto-N-difucohexaose I-APD-KLH | | |
| Lacto-N-difucohexaose I-BSA | | |
| Lacto-N-difucohexaose I-BSA (LNDFH I-BSA) (3 atom spacer) | It is a lewisb antigen linked to lactose spacer, a structure recognized by Helicobacter pylori that binds to human gastric epithelium. | |
| Lacto-N-difucohexaose II | Lacto-N-difucohexaose II, a carbohydrate compound prevalent in the biomedical industry for research purposes, has been found to impede pathogen adhesion to human intestinal cells. This realization has spurred speculation on the potential of Lacto-N-difucohexaose II as a viable candidate in the development of drug interventions for infectious maladies afflicting the gut. Equally exciting, Lacto-N-difucohexaose II may also offer promise as a cancer treatment. Synonyms: LNDFH II; Lewis A hexaose; D-Glucose, O-6-deoxy-alpha-L-galactopyranosyl-(1-3)-O-(O-6-deoxy-alpha-L-galactopyranosyl-(1-4)-O-(beta-D-galactopyranosyl-(1-3))-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1-3)-beta-D-galactopyranosyl-(1-4))-; β-D-Gal-(1-3)-[α-L-Fuc-(1-4)]-β-D-GlcNAc-(1-3)-β-D-Gal-(1-4)-[α-L-Fuc-(1-3)]-D-Glc. Grades: ≥95%. CAS No. 62258-12-2. Molecular formula: C38H65NO29. Mole weight: 999.91. | |
| Lacto-N-difucohexaose IV | Lacto-N-difucohexaose IV, recognized as a pivotal compound constituent, presents itself as a prospective remedial aide for an array of ailments like bacterial and viral infections. By focusing on distinct receptors and impeding the proliferation of malevolent microorganisms, this indispensable compound extensively contributes to the research of pathogenic infections. Its exceptional efficacy renders it an invaluable compound for biomedical drug advancement. Synonyms: LNDFH IV. Molecular formula: C38H65NO29. Mole weight: 999.91. | |
| Lacto-N-difucopentaose I | Cas No. 221224-60-8. | |
| Lacto-N-fucopentaose I | Lacto-N-fucopentaose I (LNFPI) is a human milk oligosaccharide (HMO), possessing antiviral and antibacterial activity. Lacto-N-fucopentaose I can reduce capsid protein VP1 to block virus adsorption, promote CDK2 and reduce cyclin E to recover cell cycle S phase block. Lacto-N-fucopentaose I inhibits ROS production and Apoptosis in virus-infected cells. Lacto-N-fucopentaose I can also regulate intestinal microbiota to affect immune system development. Synonyms: LNFP I; Fuc-a-1,2-Gal-b-1,3-GlcNAc-b-1,3-Gal-b-1,4-Glc; Blood group O(H) type I determinant; α-l-fuc(1?2)-β-d-gal-(1?3)-β-d-glcnac-(1?3)-β-d-gal-(1?4)-d-glc; 6-Desoxy-α-L-galactopyranosyl-(1->2)-β-D-galactopyranosyl-(1->3)-2-acetamido-2-desoxy-β-D-glucopyranosyl-(1->3)-β-D-galactopyranosyl-(1->4)-D-glucose. Grades: ≥95%. CAS No. 7578-25-8. Molecular formula: C32H55NO25. Mole weight: 853.77. | |
| Lacto-N-fucopentaose I-biotin | Lacto-N-fucopentaose I-biotin - a bio-reagent in the biomedical industry. It helps researchers detect and analyze fucosylated oligosaccharides. Its biotin modification provides tactical binding options, leading to a better understanding of fucosylation events in biological processes such as pathogen binding, cancer development, and more. Molecular formula: C48H82N6O27S. Mole weight: 1207.26. | |
| Lacto-N-fucopentaose I-BSA | | |
| Lacto-N-fucopentaose I-BSA (LNFP I-BSA) (3 atom spacer) | Lacto-N-fucopentaose I-BSA (LNFP I-BSA) (3 atom spacer) is an instrumental biomedical tool employed to unravel the intricate molecular interplay between proteins and carbohydrates. This glycoprotein conjugate harbors the enigmatic Lacto-N-fucopentaose I, a sui generis complex carbohydrate that adorns cell surfaces and resides in body fluids. The product's salience lies in its ability to diagnose and treat a plethora of ailments including cancers, infections, and inflammation. | |
| Lacto-N-fucopentaose II | Lacto-N-fucopentaose II (LNFP II) is a sialyl-Lewis, hapten of human Lewis bloodgroup determinant. Lacto-N-fucopentaose II monosialo-ganglioside/glycolipid and sialyl derivative, CA 19-9, is a molecular tumour markers (TM) for biliopancreatic malignancy [1]. Uses: Scientific research. Group: Natural products. Alternative Names: LNFP II. CAS No. 21973-23-9. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-N7575. | |
| Lacto-N-fucopentaose II | It is a human milk oilgosaccharide that can be associated with some gastrointestinal tumors. Synonyms: LNFP II; Lewisa antigen; Lewis A antigen; b-D-Gal-(1?3)-(a-L-Fuc-[1?4])-b-D-GlcNAc-(1?3)-b-D-Gal-(1?4)-D-Glc; β-D-Galp-(1?3)-[α-L-Fucp-(1?4)]-β-D-GlcpNAc-(1?3)-β-D-Galp-(1?4)-D-Glcp; Lewis-a pentasaccharide; LNF II; Lacto-N-fucopentaose-2; Lea penta. Grades: ≥95%. CAS No. 21973-23-9. Molecular formula: C32H55NO25. Mole weight: 853.77. | |
| Lacto-N-fucopentaose II-APD-HSA | | |
| Lacto-N-fucopentaose II-APD-KLH | Lacto-N-fucopentaose II-APD-KLH is an extraordinary bioactive compound prevalent in the biomedical sector, exhibitionizes immense promise for research across diverse diseases through its remarkable affinities for selective receptors, namely Fucosyltransferase and Galectins. It has garnered extensive utilization within research domains aiming to unravel the intricacies of cancer, inflammation and immune-related maladies, as well as devising innovative strategies for their effective research. | |
| Lacto-N-fucopentaose II-BSA | | |
| Lacto-N-fucopentaose II-BSA (LNFP II-BSA) (3 atom spacer) | Lacto-N-fucopentaose II-BSA (LNFP II-BSA) (3 atom spacer), a biomedicine product designed for unravelling the mysteries of glycan-protein interactions. Widely employed for diagnosis of Helicobacter pylori (H. pylori) in serum samples of infected individuals, its applications extend beyond the laboratory. Studies have revealed its crucial role in illuminating the intricacies of carbohydrate-mediated ailments such as cancer and inflammation. | |
| Lacto-N-fucopentaose II-GEL | Lacto-N-fucopentaose II-GEL is a paramount biomedical compound, serving as a tool for deciphering intricate complexities attributed to the functions and interplays of carbohydrates within cellular systems. By facilitating the detection of lectins, glycosylation analysis and exploration of carbohydrate impacts on disease advancement, this product assumes a pivotal significance. Its indispensability lies in unraveling the pathogenesis of specific ailments and forging prospects for prospective researchs. | |
| Lacto-N-fucopentaose III | It is a human milk oilgosaccharide that can inhibit the adherence of pathogens to the intestinal epithelium. Synonyms: LNFP III; Lewis X antigen; Gal-b-1,4-(Fuc-a-1,3)-GlcNAc-b-1,3-D-Gal-b-1,4-Glc; Lex-lactosel; Lewis-X pentasaccharide; β-D-Galp-(1?4)-[α-L-Fucp-(1?3)]-β-D-GlcpNAc-(1?3)-β-D-Galp-(1?4)-D-Glcp; O-6-deoxy-alpha-L-galactopyranosyl-(1->3)-O-[beta-D-galactopyranosyl-(1->4)]-O-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-O-beta-D-galactopyranosyl-(1->4)-D-Glucopyranose; 6-Deoxy-α-L-galactopyranosyl-(1->3)-[β-D-galactopyranosyl-(1->4)]-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1->3)-β-D-galactopyranosyl-(1->4)-D-glucose; Lacto-N-neofucopentaose II. Grades: ≥95%. CAS No. 25541-09-7. Molecular formula: C32H55NO25. Mole weight: 853.77. | |
| Lacto-N-fucopentaose III-APD-HSA | | |
| Lacto-N-fucopentaose III-BSA | | |
| Lacto-N-fucopentaose III-BSA (LNFP III-BSA) (3 atom spacer) | Lacto-N-fucopentaose III-BSA (LNFP III-BSA) (3 atom spacer) is an astounding specialized biomedical wonder, harbors immense value for the scientific realm. This groundbreaking product unravels the intricacies behind carbohydrate-protein interactions, facilitating a comprehensive understanding of this enigmatic domain. A conjugate brimming with potential, LNFP III-BSA amalgamates the captivating carbohydrate structure of Lacto-N-fucopentaose III with the mighty Bovine Serum Albumin (BSA) and an elegant 3 atom spacer. Its importance transcends mere investigation, offering invaluable insights into drug development and the intricate pathology of diseases intricately linked to carbohydrate recognition. Prepare to embark on an academic odyssey like no other, courtesy of LNFP III-BSA. | |
| Lacto-N-fucopentaose III-GEL | Lacto-N-fucopentaose III-GEL is an advanced biomedical product engineered to precisely target and study diverse malignancies, including breast, ovarian and colon cancers. This exceptional gel conjugate seamlessly integrates the distinctive attributes of Lacto-N-fucopentaose III is a specific carbohydrate molecule, with a sophisticated gel matrix, thereby ensuring optimal drug administration and localized research. Through its selective adherence to cancerous cells, this compound holds remarkable prospects for individualized therapy, ultimately enhancing patient prognosis substantially. | |
| Lacto-N-fucopentaose V | Lacto-N-fucopentaose V, a groundbreaking biomedicine product, emerges as a pivotal therapeutic entity in the daunting battle against several diseases. Extensive scientific investigations have unraveled its potential prowess in cancer therapy by augmenting immune responses to combat malignant neoplasms. Moreover, its remarkable attributes offer hope in alleviating inflammatory bowel disease through the regulation of gut-associated inflammatory reactions. Synonyms: LNFPV; Galb1-3GlcNAcb1-3Galb1-4(Fuca1-3)Glc. CAS No. 60254-64-0. Molecular formula: C32H55NO25. Mole weight: 853.77. | |
| Lacto-N-fucopentaose VI | Lacto-N-fucopentaose VI is an esteemed biomedical compound, standing tall as a prodigious therapeutic ally in studying multifarious ailments. Abounding in cascading units of fucose and lactosamine, this exquisite glycan has sparked rapt attention. Careful scrutiny has unveiled its prodigious potentialities in revolutionizing the domain of cancer inhibition, inflammation mitigation and bacterial afflictions. Delve deeper into its astounding architecture and intricate workings is as it emerges as a beacon of hope in the realms of targeted compound transportation and immunotherapeutic compounds. Synonyms: LNFP VI; D-Glucose, O-β-D-galactopyranosyl-(1?4)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1?3)-O-β-D-galactopyranosyl-(1?4)-O-[6-deoxy-α-L-galactopyranosyl-(1?3)]-; Gal-b-1,4-GlcNAc-b-1,3-Gal-b-1,4-[Fuc-a1,3]Glc. Grades: 95%. CAS No. 145876-86-4. Molecular formula: C32H55NO25. Mole weight: 853.77. | |
| Lacto-N-hexaose | Lacto-N-hexaose is an esteemed and extensively employed compound with field assuming a pivotal position in the research of numerous afflictions such as gastrointestinal disorders and viral infections. By virtue of its distinctive structural composition, Lacto-N-hexaose showcases an unparalleled therapeutic capacity, thereby stimulating optimistic prospects for the creation of innovative pharmaceutical compounds intended to study these exigencies. Synonyms: LNH; LNThex; D-Glucose, O-beta-D-galactopyranosyl-(1-3)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1-3)-O-(O-beta-D-galactopyranosyl-(1-4)-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1-6))-O-beta-D-galactopyranosyl-(1-4)-; β-D-Gal-(1?3)-β-D-GlcNAc-(1?3)-(β-D-Gal-[1?4]-β-D-GlcNAc-[1?6])-β-D-Gal-(1?4)-D-Glc. Grades: ≥95%. CAS No. 64003-51-6. Molecular formula: C40H68N2O31. Mole weight: 1072.96. | |
| Lactonic (di-acetylated) Sophorolipids | Lactonic sophorolipid is a natural antimicrobial surfactant for oral hygiene. Lactonic sophorolipid, a potential anticancer agent, induces apoptosis in human HepG2 cells through the caspase-3 pathway. Uses: Widely used in oilfield field, environmental remediation field, agriculture, animal husbandry and aquaculture fields, daily chemicals, cleaning, personal care: it can replace chemical surfactants, with excellent surface performance, safety, biodegradability, strong detergency, low foam type and easy to rinse. Synonyms: 17-L-[(2'-O-β-D-Glucopyranosyl-β-D-glucopyranosyl)oxy]-cis-9-octadecenoic acid 1',4"-lactone 6',6"-diacetate. CAS No. 148409-20-5. Molecular formula: C34H56O14. Mole weight: 688.80. | |
| Lactonic (di-acetylated) Sophorolipids | Non-ionic Detergents. Alternative Names: 17-L-[(2'-O-b-D-Glucopyranosyl-b-D-glucopyranosyl)oxy]-cis-9-octadecenoic acid 1',4'-lactone 6',6"-diacetate. CAS No. 148409-20-5. Molecular formula: C34H56O14. Mole weight: 688.8. Appearance: White to light yellow to beige powder to crystalline powder or solid. Purity: ≥85%. IUPACName: [(1S, 3R, 4S, 5S, 6R, 8R, 10S, 17Z, 28S, 29R, 31R, 32R)-29-(acetyloxymethyl)-4, 5, 31, 32-tetrahydroxy-10-methyl-26-oxo-2, 7, 9, 27, 30-pentaoxatricyclo[26.2.2.03, 8]dotriacont-17-en-6-yl]methyl acetate. Density: 1.152±0.06 g/cm³ (Predicted). |  |
| Lactonic Sophorolipid | Lactonic Sophorolipid. Synonyms: Lactonic (di-acetylated) Sophorolipids. CAS No. 148409-20-5. Pack Sizes: 25 kg. Product ID: CDC10-0372. Molecular formula: C34H56O14. Category: Cosmetic Surfactants. Product Keywords: Cosmetic Ingredients; Cosmetic Surfactants; Lactonic Sophorolipid; CDC10-0372; 148409-20-5; C34H56O14; Lactonic (di-acetylated) Sophorolipids; 148409-20-5. Purity: 0.5. Color: Light yellow to brown. Physical State: Liquid. Storage: Keep tightly closed. Avoid light and keep in cool and dry condition. Boiling Point: 843.8±65.0 °C(Predicted). Density: 1.152±0.06 g/cm3(Predicted). Product Description: Lactonic sophorolipid is a natural antimicrobial surfactant for oral hygiene. Lactonic sophorolipid, a potential anticancer agent, induces apoptosis in human HepG2 cells through the caspase-3 pathway. |  |
| Lacto-N-neodifucohexaose | Lacto-N-neodifucohexaose is a remarkable and prodigious compound, unveiling its colossal potentiality in an extensive array of ailments' therapies. Profoundly deviating from the conventional medicine panorama, this extraordinary compound manifests its profound therapeutic proficiencies through the prophylaxis of bacterial invasions is amplification of the immune system's prowess and alleviation of inflammation. Emanating as an epitome of immunomodulation, it has exhibited compelling outcomes when studying selected malignancies and gastrointestinal disorders. Furthermore, Lacto-N-neodifucohexaose serves as an invaluable diagnostic apparatus, proficiently identifying peculiar pathogens alongside distinct markers linked to sundry diseases. Synonyms: Gal-b-1-4(Fuc-a-1-3)GlcNAc-b-1-3Gal-b-1-4(Fuc-a-1-3)Glc; Lewis X hexaose; LNnDH. Molecular formula: C38H65NO29. Mole weight: 999.93. | |
| Lacto-N-neodifucohexaose II | Lacto-N-neodifucohexaose II is a highly esteemed compound in the biomedical sector, emerging as an invaluable resource boasting promising proclivities for studying specified ailments and circumstances. Delving into its potential therapeutic aptitudes concerning distinct pharmacological targets and disorders necessitates unwavering dedication towards empirical scientific investigations and meticulous clinical experimentation. Any inquisitive souls yearning for a comprehensive grasp of its multifaceted utilities and inherent characteristics are urged to peruse the instructive web portals duly mentioned for comprehensive elucidation. Molecular formula: C38H65NO29. Mole weight: 999.91. | |
| Lacto-N-neofucopentaose | Lacto-N-neofucopentaose is a compound product used for investigating the role of carbohydrates in various diseases. This compound can be utilized for studying the binding properties and interactions with lectin proteins is aiding in the research of cancer, inflammation and microbial infections. Synonyms: Gal-b-1-4-GlcNAc-b-1-3-Gal-b-1-4(Fuc-a-1-3)Glc. Molecular formula: C32H55NO25. Mole weight: 853.77. | |
| Lacto-N-neohexaose | Lacto-N-neohexaose is a cutting-edge compound with remarkable anti-inflammatory powers, aiding in the research of autoimmune disorders, most notably rheumatoid arthritis. Synonyms: D-Glucose, O-β-D-galactopyranosyl-(1?4)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1?3)-O-[O-β-D-galactopyranosyl-(1?4)-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1?6)]-O-β-D-galactopyranosyl-(1?4)-; O-β-D-Galactopyranosyl-(1?4)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1?3)-O-[O-β-D-galactopyranosyl-(1?4)-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1?6)]-O-β-D-galactopyranosyl-(1?4)-D-glucose. Grades: ≥90%. CAS No. 64003-52-7. Molecular formula: C40H68N2O31. Mole weight: 1072.96. | |
| Lacto-N-neooctaose | Lacto-N-neooctaose is a biomedical product, emerging as a prebiotic and fomenting substantial research in gut health. Synonyms: Gal-b-1-4-GlcNAc-b-1-3-Gal-b-1-4-GlcNAc-b-1-3-Gal-b-1-4-GlcNAc-b-1-3-Gal-b-1-4-Glc; LNnO. Molecular formula: C54H91N3O41. Mole weight: 1438.30. | |
| Lacto-N-neotetraosa-APD-HSA | | |
| Lacto-N-neotetraose | Lacto-N-neotetraose (LNnT) is an endogenous metabolite. Lacto-N-neotetraose can inhibit TNF-α induced IL-8 secretion in immature epithelial cells. Lacto-N-neotetraose has anti-inflammatory avtivity, and can improve the wound closure [1] [2] [4]. Uses: Scientific research. Group: Natural products. Alternative Names: LNnT. CAS No. 13007-32-4. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-N9445. | |
Our database is helping our users find suppliers everyday.
